BPMC Blueprint Medicines91.05+3.48 (+4.0%)
BPMC Blueprint Medicines87.25-0.36 (-0.4%)
BPMC Blueprint Medicines82.49+1.50 (+1.9%)
BPMC Blueprint Medicines67.42+4.30 (+6.8%)
BPMC Blueprint Medicines58.38+0.77 (+1.3%)
Premarket Decliner
BPMC Blueprint Medicines44.29+0.22+0.5%
Premarket:41.06-3.23 (-7.3%)
Blueprint Medicines Announces Partial Clinical Hold for Phase 1/2 VELA Trial of BLU-222
PRNewswireFri, 10-Feb 8:00 AM